Neurodegenerative disorders Flashcards

(34 cards)

1
Q

what are neurodegenerative diseases

A

ensemble of conditions primarily affecting the neurons in the human brain

frequently culminate in neuronal cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are neurons prone to

A

o2 lack- 3 mins to death (VASCULAR)
degenerative triggers
-stress
-immuno-sensitive
-toxic aggregates
-trauma
-age

POOR REGENERATIVE POWERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when is dementia conventionally diagnosed

A

when progressive cognitive decline has occurs
this has had a noticeable impact upon a persons ability to carry out important everyday activities
defined according to the EXTENT of brain failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when do the pathological changes of dementia start

A

likely commenced well in advance to symptoms presenting
(15-30 years)
therefore how do you reverse cell death that has already occurred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define cognition in relation to brain function
what are the 5 DOMAINS of cognition

A

the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses

  1. learning and memory
  2. language
  3. visuo-spatial function
  4. executive function
  5. psychomotor abilities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are 10 signs of dementia

A

poor/ decreased judgement
difficulty with simple tasks
problems communicating
misplacing things
dat-to-day forgetfulness
problems with language
difficulty solving problems
confusion of time/place
changes in personality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is dementia
diagnosis
treatment

A

chronic
often global
irreversible deterioration of cognition

rule out vascular/tumour cause
but cant differentiate between different kinds of dementia
-lab and imaging
POST MORTEM ONLY DEFINITICE DIAGNOSTIC

lack reliable biomarkers

SUPPORTIVE treatment (no cure/reversing treatment)

CHOLINESTERASE INHIBITORS- temporarily improve cognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is dementia
diagnosis
treatment

A

chronic
often global
irreversible deterioration of cognition

rule out vascular/tumour cause
but cant differentiate between different kinds of dementia
-lab and imaging
POST MORTEM ONLY DEFINITICE DIAGNOSTIC

lack reliable biomarkers

SUPPORTIVE treatment (no cure/reversing treatment)

CHOLINESTERASE INHIBITORS- temporarily improve cognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what test do you do for frontal lobe
-sequencing, verbal fluency

A

luria hand sequencing task
verbal fluency 1 minute words

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what test do you do for temporal lobes
-memory, speech

A

address test
object recall
serial 7s (100-7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what test do you do for parietal lobes
-spatial awareness (R)
-language (L)

A

clock face
naming objects
drawing cube, interlocking infinity
agnosia (name object with closed eye)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what screening tests are there for detecting dementia

A
  1. MINI-MENTAL STATE EXAMINATION (MMSE)
    -not good at discriminating (have to be very demented)
  2. ADDENBROOKE’S COGNITIVE EXAMINATION III
    -good differentiation between dementia, MCI and controls but not dementia subtypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the difference between sensitivity and specificity
AND MMSE vs ACE III

A

sensitivity- TRUE POSITIVE
specificity- TRUE NEGATIVE

ace has higher sensitivity and specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is mild cognitive impairment

A

(grey zone)
cognitive impairment greater than age related impairment
decline in function of 1 or more of the 5 cognitive domains

no ADL impairment

it might progress to dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

is alzheimers predominant in female or men
and how does it present

A

female

early memory disturbance
progress to dyspraxia and dysphasia
eventually immobile and mute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the signature proteins of AD
(aggregates)

A

INTRACELLULAR in cytoplasm
-phosphorylated TAU proteins
-neurofibrillary tangles

EXTRACELLULAR
-amyloid plaques
-AB peptides

16
Q

what are the risk factors of dementia

A

less education
hypertension
hearing impairment
smoking
obesity
depression
physical inactivity
diabetes
infrequent social contact
(xs alcohol, TBI, air pollution)

12 modifiable risk factors account for 40% of worldwide dementias
–could theoretically be prevented or delayed

17
Q

what are specific recommended actions to reduce risk of dementia

A

maintain BP (130 or less)
use of hearing aids- reduce noise induced hearing loss
reduce air pollution exposure, second hand tobacco smoke
reduce head injury
limit alcohol use <21 units a week
avoid smoking
provide primary and secondary education

18
Q

how do amyloid precursor peptide cleavage patterns determine plaque formation

A

-Membrane protein processed
in secretory pathway
-Cleaved by secretases
-If beta secretase acts Abeta
fragments with 38-42 amino
acids generated
-Less soluble and aggregate
extracellularly to make
fibrils/plaques

19
Q

what are some major risk genes associated with AD
in particular familial alzheimers

A

ApoE4- membrane trafficking
TREM2- recycling
SORL1-sorting

ENDOSOMAL MEMBRAINE TRAFFICKING PROBLEMS

familial forms:
changes in amyloid precursor protein
and presemilin gene

20
Q

what is the retromer complex
and what happens in AD patients

A

involved in endosomal protein sorting back to surface for reuse

key components of retromer are depressed in hippocampus of AD patients
–causes mixing of B secretase and APP, aberrant trafficking
this causes AB production and TAU increases

21
Q

what are some biomarkers

A

structure:
CT, MRI

functional PET
amyloid PET
tau PET

EXPENSIVE, DONT PROVIDE A SCREENING TOOL

CSF studies- why if cant differentiate and cant treat, why put patient through that

peripheral blood samples- more accessible, promising

MAINLY CLINICAL

22
Q

Ach and dementia
what drug can you use

A

marked loss of Ach (mainly responsible for memory and learning defect)
-related to neuronal loss from nucleus basalis of Meynert

DONEPEZIL (most affective in mild-moderate)

MEMANTINE (moderate to severe)

23
Q

what does MEMANTINE target

A

glutamate is off target from astrocytes
on extra-synaptic NMDA (glutamate receptors)
stimulate death pathways

so block flow though glutamate channels
affect function of receptors and block death pathways

NMDA receptor antagonists

24
what is ADUHELM
immunoglobulin gamma 1 antibody against amyloid beta (rid aggregates) clinical effectiveness questionable probs wont be approved in uk
25
discuss vascular dementia
often mixed with AD can identify vascular features history of stroke/vascular disease/ risk factors
26
what is the toxic aggregate found in parkinsons
a-synuclein accumulation also found in lewy body dementia
27
what is the difference between parkinsons and lewy body dementia
parkinsons usually start with movement disorder can develop into dementia lewy body starts with dementia and parkinsonism movement disorder both have a-synuclein accumulation
28
what is common with alzheimers and parkinsons
membrane sorting components defect difficulty to degrade aggregates
29
what is amyotrophic lateral sclerosis
both upper and lower motorneurones die * fasciculations (muscle twitches) in the arm, leg, shoulder, or tongue * muscle cramps * tight and stiff muscles (spasticity) * muscle weakness affecting an arm, a leg, neck or diaphragm. * slurred and nasal speech * difficulty chewing or swallowing. overlaps with frontotemporal dementia
30
what are some genes found in ALS and mechanisms
5-10% familial C9orf72 is most common mutation (also found in FTD) CAUSES AGGREGATION OF TDP-43 -causes stress and glutamate toxicity related death protein aggregates (SOD1) Excitoxicity- glutamate transport is reduced (EAAT2), glutamate increased in CSF mitochondrial dysfunction caused by SOD1- DNA damage astrocytes play a role in neuron toxicity via SOD1 mechanisms
31
what is RILUZOLE
reduces glutamate release increases astrocyte glutamate uptake decrease levels inhibits TDP43 metabolism improve glutamate transporter EAAT2
32
what are treatments for ALS
RILUZOLE EDARAVONE
33
what are some types of motorneurone disease
amyotrophic lateral sclerosis UMN/LMN (lou gehrig's disease) progressive muscular atrophy LMN primary lateral sclerosis UMN spinal muscular atrophy